CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹158 Cr | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹149 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹100 Cr |
How is Long Term Provisions of CIPLA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | 5.97 | |
| Mar2025 | ₹149 Cr | 15.03 | |
| Mar2024 | ₹129 Cr | 26.53 | |
| Mar2023 | ₹102 Cr | 1.94 | |
| Mar2022 | ₹100 Cr | - | |
Compare Long Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,145.5 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| MANKIND PHARMA | ₹101,638.0 Cr | -5.1% | -3.1% | -2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.6% |
-1.4% |
-6.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses